- GCV Symposium keynote interview: “As investors, we need… •
- GCV Symposium panel: Energy and Mobility •
- GCV Symposium fireside chat: Looking beyond the short… •
- GCV Symposium keynote: CVCs as change agents •
- Daily Deal Round Up: May 18, 2022 •
- Corporate venturing grows tepidly in April •
- Britain’s innovation space is stronger than ever despite… •
- Covid-19 drove more corporations to explore venture capital •
- Why do many Venture Capital Funded Start-ups shut… •
- Media sector still in the game after the… •
- Security provides the platform •
- Booming CVC is about to get a reality… •
Healthcare
Daily Deal Round Up: May 18, 2022
The Global Corporate Venturing deal net rounds up investments from across the corporate innovation ecosystem.
Daily Deal Round Up: May 17, 2022
The Global Corporate Venturing deal net rounds up investments from across the corporate innovation ecosystem.
Daily Deal Round Up: May 13, 2022
The Global Corporate Venturing deal net rounds up the smaller investments from across the corporate innovation ecosystem.
Daily Deal Round Up: May 12, 2022
The Global Corporate Venturing deal net rounds up the smaller investments from across the corporate innovation ecosystem.
Daily Deal Round Up: May 11, 2022
The Global Corporate Venturing deal net rounds up the smaller investments from across the corporate innovation ecosystem.
Daily Deal Round Up: May 10, 2022
The Global Corporate Venturing deal net rounds up the smaller investments from across the corporate innovation ecosystem.
Daily Deal Round Up: May 9, 2022
The Global Corporate Venturing deal net rounds up the smaller investments from across the corporate innovation ecosystem.
Daily Deal Round Up: May 6, 2022
The Global Corporate Venturing deal net rounds up the smaller investments from across the corporate innovation ecosystem.
Other News
Daily Deal Round Up: May 5, 2022
The Global Corporate Venturing deal net rounds up the smaller investments from across the corporate innovation ecosystem.
Daily Deal Round Up: May 4, 2022
The Global Corporate Venturing deal net rounds up the smaller investments from across the corporate innovation ecosystem.
Suzuken to seek out corporate venturing deals
The drug wholesaler’s CVC fund will have up to $39.3m in capital, and will be led by Suzuken's head of corporate strategy, Yuichi Yamamoto.
Daily Deal Round Up: May 3, 2022
Web3 services provider Venly and genomic analysis technology provider Genome Insight each raised $23m while Rui Ye Lian helped Cedarlake Capital close a $189m fund.
HilleVax racks up $200m in its IPO
The Takeda Vaccines spinoff floated in an upsized offering that granted its former parent $100m in shares.
OMass Therapeutics binds to $100m series B
Alphabet, Sanofi and Syncona were among the investors helping the drug developer advance toward clinical trials.
Editor's Picks
MassMutual Ventures assembles $300m fund
Massachusetts Mutual Life's venture capital arm has formed a fourth fund, which will concentrate on European and Asia-Pacific investments.
M Ventures embraces technology demand
With a remit across healthcare, life sciences and advanced materials, Merck’s corporate venturing unit is scoping an opportunity-filled landscape.
J&J forms New Company (NewCo) Creation unit
Johnson & Johnson pivots earlier stage, reflected in the NewCo Creation unit it set up.
GenFleet generates $75m in series C funding
Baidu Ventures has backed the small molecule cancer therapy developer’s latest round, which came after a slew of healthtech and biotech investments made by the unit in recent months.
About us
Global Corporate Venturing (GCV) is where global innovation and capital converge to define, invest and shape the world of tomorrow. We provide the world’s investors and the wider innovation ecosystem with the information, insights, collaboration and access they need to succeed in a constantly changing world.
Navigation
